Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 666

Results For "AI"

6937 News Found

Morepen to start Sputnik V Vaccine commercial production in 4-6 weeks
News | July 28, 2021

Morepen to start Sputnik V Vaccine commercial production in 4-6 weeks

The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval


Sun Pharma signs Cassiopea for license and supply agreements
News | July 27, 2021

Sun Pharma signs Cassiopea for license and supply agreements

Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older


Kilitch starts injectables production at Ethiopia
News | July 27, 2021

Kilitch starts injectables production at Ethiopia

The Cephalosporin Injectables plant has a total capacity of 26.4 million vials per year while Ethiopia is having a demand for 16 million vials


Sun Pharma Advanced Research Company Q1FY22 loss at Rs. 61.37 Cr
News | July 27, 2021

Sun Pharma Advanced Research Company Q1FY22 loss at Rs. 61.37 Cr

The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.


GlaxoSmithKline delivers 19% revenue growth for Q1 FY22
News | July 27, 2021

GlaxoSmithKline delivers 19% revenue growth for Q1 FY22

The company has decided to transfer our rights in relation to the lodex and Ostocalcium brands to GlaxoSmithKline Asia Private Limited


Alembic Pharmaceuticals Q1FY22 net slides to Rs. 164.52 Cr
News | July 27, 2021

Alembic Pharmaceuticals Q1FY22 net slides to Rs. 164.52 Cr

The US business faced price erosion due to increased competition.


Lasa production to commence in couple of weeks
News | July 27, 2021

Lasa production to commence in couple of weeks

The company is confident of commencing production at both Mahad and Chiplun units soon


Biocon Biologics partners Adagio to manufacture antibody for COVID-19
News | July 27, 2021

Biocon Biologics partners Adagio to manufacture antibody for COVID-19

ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses


Panacea Biotec posts consolidated loss of Rs. 57.35 Cr in Q1FY22
News | July 26, 2021

Panacea Biotec posts consolidated loss of Rs. 57.35 Cr in Q1FY22

It posted net (loss) of Rs.(34.13) crores for the period ended June 30, 2020.


Glenmark Life Sciences IPO to open on July 27, 2021
News | July 26, 2021

Glenmark Life Sciences IPO to open on July 27, 2021

The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration